Dr. John Nicholas Melvan, MD, PhD

Dr. Melvan practices at Memorial Regional Hospital South in Hollywood, Florida.

Dr. Melvan's NPI, 1205279411, was assigned on April 8, 2013. Dr. Melvan graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2013. Dr. Melvan holds Florida license 139813.

Dr. Melvan's primary practice is Memorial Regional Hospital South, at 3600 Washington St, Hollywood, FL 33021 in Broward County. The practice phone is (954) 966-4500.

Dr. Melvan's primary practice is Memorial Regional Hospital South in Hollywood, Florida. Dr. Melvan is also affiliated with Memorial Regional Hospital. The medical group on file is Memorial Division of High Risk Obstetrics. Dmand AI also links Dr. Melvan to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melvan practices, 3 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Melvan's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Melvan is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. Dmand AI has Dr. Melvan's licenses on file in 2 states: Florida and Idaho.

Dmand AI lists heart bypass surgery, heart valve surgery and lung resection among the conditions Dr. Melvan treats.

CMS data shows 14 Medicare services from Dr. Melvan across 1 procedure code in 2024, for 36 Medicare patients. Medicare paid $1,937 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 36 Medicare patients who saw Dr. Melvan in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have heart failure, and 75% have high blood pressure. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Melvan's median patient age at 72, with 39% women.

In 2024, Dr. Melvan wrote 221 Medicare Part D claims for 43 patients. 93% of them were for generic drugs. CMS names the drug for 152 of them, across 8 drugs with 11 or more claims each, at $702 in total drug cost. In 2023, CMS named 38 claims across 2 drugs.

Dr. Melvan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary artery bypass graft (CABG): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Melvan, published from 2011 to 2024. 2015 was the busiest year, with 3. The most frequent topics are Antigens, Ly, Bone Marrow Cells and Cardiac Surgical Procedures. Dr. Melvan has published most often in Ann Thorac Surg. Dr. Melvan's most frequent co-authors are Seth D. Force, MD, Manu Suraj Sancheti, MD and Jacob S. Delarosa, MD.

CMS Open Payments shows 67 general payments to Dr. Melvan from 12 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 56% of the total. Edwards Lifesciences Corporation paid the most, $3,208.

Dr. Melvan graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2013. Dr. Melvan is a member of ACC, ACS and Society of Thoracic Surgery.

Dr. Melvan is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.